Enzyme

Monoamine oxidase B

Monoamine oxidase B

  • GeneMAOB
  • FamilyMonoamine oxidases

The monoamine oxidases play a vital role in the metabolism of biogenic amines in the central nervous system and in peripheral tissues. In 1988 cDNAs of the A and B forms were isolated from human liver with oligonucleotide probes derived from three sequenced peptide fragments. The two forms have subunit molecular weights of 59,700 and 58,800 and 70 percent sequence identity. Both contain the pentapeptide Ser-Gly-Gly-Cys-Tyr, in which the cofactor FAD is covalently bound to cysteine, and they appear to derive from separate genes.1 Human platelets contain only MAO B and are often used as an indicator of brain MAO B. The deduced amino acid sequences of MAO B from human frontal cortex, platelet and liver are identical.2

MAO B is a mitochondrial outer-membrane flavoenzyme and a well-known target for antidepressant and neuroprotective drugs. The structure of the human enzyme was determined to 3 Å resolution in 2002. The enzyme binds to the membrane through a C-terminal transmembrane helix and apolar loops. Pargyline, an analog of the clinically used MAO B inhibitor deprenyl, binds covalently to the flavin N5 atom. The recognition site for the substrate amino group is an aromatic cage formed by Tyr 398 and Tyr 435.3

Sources (3)
  1. Bach et al. 1988Bach AW, Lan NC, Johnson DL, et al. (1988) cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties Proc Natl Acad Sci U S A
  2. Chen et al. 1993Chen K, Wu HF, Shih JC (1993) The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identical J Neurochem
  3. Binda et al. 2002Binda C, Newton-Vinson P, Hubálek F, et al. (2002) Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders Nat Struct Biol

Binding affinity (Kᵢ)

1 substance, 1 displayed value. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.

Human

1 measurement
  • MethysticinInhibitor1140 nMUebelhack et al. 1998
    Assay
    human platelets, [14C]phenylethylamine deamination (MAO-B), disrupted platelets, competitive inhibition
    Shown value from
    Uebelhack et al. 1998, Abstract and results

Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.